References
- Cappel M. J., Kreuter J. Effect of nonionic surfactants on transdermal drug delivery I: Polysorbates. International Journal of Pharmaceutics 1991a; 69: 143–153
- Cappel M. J., Kreuter J. Effect of nonionic surfactants on transdermal drug delivery II: Poloxamer and poloxamine surfactants. International Journal of Pharmaceutics 1991b; 69: 155–167
- Cappel M. J., Kreuter J. Effect of nonionic surfactants on transdermal drug delivery II: Poloxamer and poloxamine surfactants. International Journal of Pharmaceutics, (accepted for publication) 1990b
- Douglas S. J., Illum L., Davis S. S., Kreuter J. Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles. Journal of Colloid and Interface Science 1984; 101: 149–158
- Harmia T., Kreuter J., Speiser P., Boye T., Gurny R., Kubis A. Enhancement of the myotic response of rabbits with pilocarpine loaded polybutylcyanoacrylate nanoparticles. International Journal of Pharmaceutics 1986; 33: 187–193
- Kreuter J. Possibilities of using nanoparticles as carriers for drugs and vaccines. Journal of Microencapsulation 1988; 5: 115–127
- Kreuter J. Nanoparticles as bioadhesive ocular drug delivery systems. Bioadhesive Drug Delivery Systems, V. Lenaerts, R. Gurny. CRC Press, Boca Raton 1990; 203–212
- Kreuter J., Speiser P. P. New adjuvants on a polymethylmethacrylate base. Infection and Immunity 1976a; 13: 204–210
- Kreuter J., Speiser P. P. In vitro studies of poly(methylmethacrylate) adjuvants. Journal of Pharmaceutical Sciences 1976b; 65: 1624–1627
- Kreuter J., Zehnder H. J. The use of 60Co-γ-irradiation for the production of vaccines. Radiation Effects 1978; 85: 161–166
- Kreuter J., Liehl E. Long-term studies of microencapsulated and adsorbed influenza vaccine nanoparticles. Journal of Pharmaceutical Sciences 1981; 70: 367–371
- Kreuter J., Mills S. N., Davis S. S., Wilson C. G. Polybutylcyanoacrylate nanoparticles for the delivery of (75Se)norcholestenol. International Journal of Pharmaceutics 1983; 16: 105–113